Author:
Chayama Kazuaki,Tsubota Akihito,Arase Yasuji,Saitoh Satoshi,Ikeda Kenji,Koida Isao,Morinaga Tsutoh,Kumada Hiromitsu
Reference24 articles.
1. Di Biseglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH (1989) Recombinant interferon-alfa therapy for chronic hepatitis C. N Engl J Med 321: 1056–1511
2. Davis GL, Baiart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, and the hepatitis inter-ventional therapy group (1989) Treatment of chronic hepatitis C with recombinant interferon-alfa. N Engl J Med 321: 1501–1506
3. Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobayashi M, Unakami M, Morinaga T, Kumada H (1991) Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 13: 1040–1043
4. Hagiwara H, Hayashi N, Mita E, Ueda K, Takehara T, Kasahara A, Fusamoto H, Kamada T (1991) Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alfa. Hepatology 14: 37–41
5. Garson JA, Brillanti S, Ring C, Perini P, Miglioli M, Barbara L (1992) Hepatitis C viremia rebound after successful interferon therapy in patients with chronic non-A, non-B hepatitis. J Med Virol 37: 210–214